Aristo Bio-tech An

NSE:ARISTO-SMBasic Materials

——At close · Market cap —

ARISTO-SM · Income statement · TradingHolo

INR billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Revenue	1.7	1.7	2.2	2.5	3.2	3.6	+14.3%
Cost of revenue	1.5	1.5	2.0	2.3	3.0	3.3	+11.8%
Gross profit	0.2	0.2	0.2	0.2	0.2	0.3	+48.1%
Research & development	0.0	0.0	0.0	0.0	0.0	0.0	—
Selling, general & administrative	0.0	0.1	0.1	0.0	0.0	0.0	+20.1%
Selling & marketing	0.0	0.0	0.0	0.0	0.0	0.0	−100.0%
Operating expenses	0.0	0.1	0.1	0.0	0.0	0.0	+20.1%
Operating income	0.1	0.1	0.2	0.2	0.2	0.3	+54.5%
Interest expense	0.0	0.0	0.0	0.0	0.0	0.0	−100.0%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	—
Other income / expense	0.0	(0.1)	(0.1)	(0.1)	(0.1)	(0.2)	−44.6%
Pre-tax income	0.0	0.0	0.0	0.1	0.1	0.1	+77.4%
Income tax	0.0	0.0	0.0	0.0	0.0	0.0	+79.1%
Net income	0.0	0.0	0.0	0.0	0.0	0.1	+76.8%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—
EPS, basic (per share)	2.15	2.87	6.72	5.72	5.97	10.55	+76.7%
EPS, diluted (per share)	2.15	2.87	6.72	5.72	5.97	10.55	+76.7%
EBITDA	0.0	0.1	0.1	0.1	0.1	0.2	+69.2%
Depreciation & amortization	0.0	0.0	0.0	0.0	0.0	0.0	+12.4%
Weighted average shares (shares)	4,995,000	4,995,818	5,300,892	6,810,664	6,807,800	6,808,151	+0.0%
Weighted average diluted shares (shares)	4,995,000	4,995,000	5,300,000	6,807,800	6,807,800	6,808,151	+0.0%
Gross margin	10.2%	11.2%	10.0%	7.8%	7.0%	9.1%	+2.1 pts
Operating margin	8.0%	7.9%	7.4%	6.3%	5.7%	7.7%	+2.0 pts
Net margin	0.6%	0.9%	1.6%	1.6%	1.3%	2.0%	+0.7 pts

INR billionsUpdated Tue 31 Mar ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.